0000000000457734

AUTHOR

M Di Forti

showing 24 related works from this author

EXPLORING SPECIFIC EFFECTS OF TYPE AND TIMING OF EXPOSURE TO CHILDHOOD ADVERSITY AND SYMPTOM DOMAINS IN FIRST EPISODE OF PSYCHOSIS: PRELIMINARY RESUL…

2019

childhood adversityfirst episode psychosissymptom
researchProduct

Eventi di vita stressanti in un campione di pazienti affetti da psicosi all’esordio: prevalenza, sintomatologia ed età d’esordio

2011

Introduzione: Un consistente numero di studi suggerisce un’elevata prevalenza di eventi traumatici nella storia di soggetti con disturbi psicotici (Shevlin et al, 2008). Piu’ che l’impatto di un singolo evento di vita stressante, l’esposizione cumulativa ad esperienze traumatiche sembra incrementare il rischio di psicosi (van Winkel et al, 2008). Scopo dello studio e’ valutare la prevalenza di tali eventi in soggetti al primo episodio psicotico a confronto con controlli sani e la possibile correlazione con la sintomatologia psicotica e l’età di esordio. Metodologia: In atto sono stati reclutati 74 soggetti al primo episodio psicotico (51 m, 23 f; em=26.39, ds=9.36) e 27 controlli sani (18 m…

life events first episode cannabis
researchProduct

ENVIRONMENTAL RISK FACTORS DIFFERENCES AMONG DIAGNOSTIC CATEGORIES IN EU-GEI STUDY

2019

schizophreniamajor depressionenvironmentbipolar
researchProduct

Gene X cannabis interaction: Case-only design analysis in a first-episode psychosis sample

2006

GENETICSCANNABISFEP
researchProduct

Effetti dell’uso di cannabis e sintomi psicopatologici in un campione di primi episodi psicotici

2014

Introduction: Cannabis is one of the most common substances used by patients with a first episode of psychosis. The aim of the study was to investigate the most frequent effects of cannabis use, their relationship with psychotic symptoms and characteristics of the consumption. Methods: 116 first episode psychosis were recruited, 50% of which (n=58) used cannabis lifetime. We investigated the characteristics of the consumption and the effects of cannabis using the Cannabis Experience Questionnaire-mv (CEQmv) and the psychotic symptoms using the Positive and Negative Symptoms Scale (PANSS). Results: The effects more often experienced by cannabis users were slowed down thinking and feeling to …

onset.cannabiSettore M-PSI/08 - Psicologia ClinicapsychosiSettore MED/25 - Psichiatria
researchProduct

CAN PRS FOR SCHIZOPHRENIA, BIPOLAR DISORDER AND MAJOR DEPRESSION DISTINGUISH AFFECTIVE PSYCHOSIS DIAGNOSTIC CATEGORIES? THE EU-GEI STUDY

2019

schizophreniaPRSmajor depressionbipolar
researchProduct

COGNITION, METACOGNITION AND SOCIAL COGNITION AFTER A FIRST EPISODE PSYCHOSIS. PRELIMINARY RESULTS FROM A 5-YEAR-FOLLOW-UP STUDY

2020

cognitionsocial cognitionpsychosismetacognition
researchProduct

Traumi infantili in un campione di pazienti affetti da psicosi all’esordio: associazione con psicopatologia e funzioni cognitive. Risultati prelimina…

2011

Introduzione: Numerosi studi hanno evidenziato l’associazione tra traumi infantili e psicosi (Morgan, Fisher, 2007). Sebbene inizialmente fosse enfatizzato il ruolo dell’abuso sessuale, recentemente l’associazione con l’abuso fisico e’ stata riportata come piu’ forte (Fisher et al, 2010; Rubino et al, 2009). Scopi dello studio sono valutare la prevalenza di eventi avversi infantili in un campione di soggetti al primo episodio psicotico e la sua relazione con la psicopatologia e le funzioni cognitive. Metodologia: Sono stati reclutati 74 soggetti al primo episodio psicotico (51 m, 23 f; em=26.39, ds=9.36). Sono state somministrate le seguenti interviste e test: CECA-Q (Bifulco et al, 2005) p…

trauma first episode funzioni cognitive
researchProduct

Does clinical or cognitive insight predict outcome in psychosis? Findings from a longitudinal first episode cohort

2013

Insight first episode psychosis
researchProduct

La Cannabis come fattore di rischio per i disturbi psicotici: uno studio su un campione italiano

2013

psicosicannabi
researchProduct

Is cerebral asymmetry associated with serotonin transporter in psychosis?

2006

CEREBRAL ASYMMETRYpsychosisserotonin
researchProduct

First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of…

2023

Abstract Cluster studies identified a subgroup of patients with psychosis whose premorbid adjustment deteriorates before the onset, which may reflect variation in genetic influence. However, other studies reported a complex relationship between distinctive patterns of cannabis use and cognitive and premorbid impairment that is worthy of consideration. We examined whether: (1) premorbid social functioning (PSF) and premorbid academic functioning (PAF) in childhood and adolescence and current intellectual quotient (IQ) define different clusters in 802 first-episode of psychosis (FEP) patients; resulting clusters vary in (2) polygenic risk scores (PRSs) for schizophrenia (SCZ_PRS), bipolar dis…

cannabiscannabiAdolescentBIPOLAR DISORDERADJUSTMENTGENE-ENVIRONMENT INTERACTIONSCLASSIFICATIONbipolarschizophreniaPsychiatry and Mental healthPsychotic DisordersRisk FactorsIQONSETpremorbidschizophrenia.HumansCluster AnalysisGENOME-WIDE ASSOCIATIONTRAJECTORIESdeteriorationSchizophrenia Bulletin
researchProduct

Durata di psicosi non trattata e consumo di cannabis in un campione di pazienti al primo episodio psicotico

2011

Introduzione: la durata di psicosi non trattata (DUP) nei pazienti affetti da psicosi all’esordio rappresenta un fattore predittivo dell’outcome e del decorso del disturbo (Perkins, 2005). La relazione tra consumo di cannabis e DUP è ancora controversa. In questo lavoro viene analizzato il rapporto tra DUP ed età di esordio, consumo di cannabis, funzionamento cognitivo, livello di istruzione e stato di occupazione in un gruppo di pazienti affetti da psicosi all’esordio reclutati nell’ambito dello studio SGAP (Sicilian Genetic and Psychosis) svolto in collaborazione con l’Institute of Psychiatry, King's College of London. Metodologia: sono stati reclutati 74 pazienti di età compresa tra 18 e…

FEP DUP cannabis
researchProduct

Eventi di vita stressanti in un campione di pazienti affetti da psicosi all’esordio: prevalenza, sintomatologia ed età d’esordio. Risultati prelimina…

2011

STRESS PSICOSI
researchProduct

PREVALENCE OF BULLYING AMONGST FIRST-EPISODE PSYCHOSIS PATIENTS AND UNAFFECTED CONTROLS

2012

Background:Despite increasing evidence suggesting that childhood mal-treatment is significantly associated with psychotic disorders, the role ofbullying in the later development of psychosis is still controversial (Kelle-her et al., 2008, Arseneault et al., 2011). Therefore, this study examinedthe prevalence of bullying amongst first-episode psychosis patients andunaffected controlsMethods:Data were collected from 227 first-presentation psychosis casesand 215 geographically-matched controls. Bullying was assessed as partof the Brief Life Events schedule. Patients and controls were shown acard listing 10 adverse events, including “bullying”, “sexual abuse”, “beingexpelled from school”, and a…

bullyingpsychosisFEP
researchProduct

Consumo di cannabis e pattern psicopatologico di pazienti al primo episodio psicotico: confronto tra due campioni

2011

Alcuni studi in letteratura supportano l’associazione tra consumo di cannabis, età di esordio ed espressività psicopatologica nei pazienti al primo episodio psicotico (Orlandi, 2001). Questo lavoro si propone di analizzare la gravità della sintomatologia psicotica in relazione al consumo di cannabis, confrontando due campioni di pazienti all'esordio psicotico (FEP) reclutati a Palermo e a Londra.

cannabis psicosiesordio psicosi esordio psicotico cannabis FEP
researchProduct

A first episode psychosis case-control genetic association study

2006

Background:GAP(genesandpsychosis) is a case-control studyof first episode psychosis conducted in London and Cambridge, which aims to identify genes conferring susceptibility to psychosis, and associated phenotypes including cognitive dysfunction and cerebral morphology. Methods:First episode psychosis cases have been recruited in South London and Maudsley NHS Trust and in Cambridge. A variety of demographic and clinical data have been collected. In a subset of these, neurocognitive assessments and MRIs have been performed. Samples have been taken for DNA, and in a subset for RNA and proteomic analysis. Genetic association analysis is being undertaken using a candidate gene approach. The gen…

GeneticpsychosisFEP
researchProduct

Ruolo di modulazione sulle funzioni cognitive dell’abuso di cannabis su un campione di soggetti al primo episodio psicotico

2011

CANNABIS NEUROPSICOLOGIA SCHIZOFRENIA
researchProduct

DUP AND CANNABIS CONSUMPTION IN A SICILIAN FIRST EPISODE PSYCHOTIC (FEP) SAMPLE

2011

Settore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.Settore MED/25 - PsichiatriaCANNABIS FEP PSYCHOSIS
researchProduct

THE ROLE OF CHILDHOOD TRAUMA AND COGNITIVE DEFICIT IN MODERATING THE RISK FOR PSYCHOTIC DISORDERS: A COMPARISON BETWEEN PALERMO AND SOUTH-EAST LONDON…

2011

childhood trauma; cognitive deficit; psychosischildhood traumapsychosiscognitive deficit
researchProduct

DNA METHYLATION PROFILING MIGHT SHED LIGHT ON THE BIOLOGY OF CANNABIS ASSOCIATED PSYCHOSIS

2019

DNA methylationcannabipsychosis
researchProduct

Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: The EU-GEI case-control study

2021

The work was supported by: Clinician Scientist Medical Research Council fellowship (project reference MR/M008436/1) to MDF; the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King’s College Hospital NHS Foundation Trust to DQ; DFG Heisenberg professorship (no. 389624707) to UR. National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The EU-GEI Project is funded by t…

Marijuana AbuseIMPACTPoison controlCannabis usecannabis-associated psychosis0302 clinical medicineSCHIZOPHRENIASettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.health care economics and organizationsApplied PsychologyRISKOUTCOMESbiologyHuman factors and ergonomics/dk/atira/pure/subjectarea/asjc/2700/2738psychopathologyCannabis use; cannabis-associated psychosis; first episode psychosis; psychopathology; psychotic experiences; symptom dimensions3. Good healthPsychiatry and Mental healthSchizophreniaHEALTHPsychopathologyPsychosismedicine.medical_specialtyDISORDERSeducationsymptom dimensions03 medical and health sciencesInjury preventionfirst episode psychosismedicineHumanspsychotic experiencesPsychiatryABUSESettore MED/25 - PsichiatriaSUBSTANCE USEMETAANALYSISCannabisbusiness.industryCase-control studyOriginal Articlesmedicine.diseasebiology.organism_classification030227 psychiatrypsychotic experiencePsychotic Disordersfirst episode psychosiCase-Control StudiesONSETGene-Environment Interaction/dk/atira/pure/subjectarea/asjc/3200/3202Cannabisbusinesscannabis-associated psychosi030217 neurology & neurosurgery
researchProduct

GENE AND ENVIRONMENT INTERPLAY AMONG DIAGNOSTIC CATEGORIES IN THE EUGEI STUDY

2020

schizophreniabipolarGxE
researchProduct

Ruolo dell'insight nell'espressività psicopatologica in un gruppo di pazienti affetti da psicosi all'esordio

2011

Una buona capacità di insight pare costituire un fattore predittivo di minore espressività psicopatologica nei pazienti affetti da psicosi. In questo lavoro intendiamo analizzare le relazioni tra grado di insight e gravità dei sintomi psicotici utilizzando i punteggi totali e parziali ottenuti alla Positive and Negative Syndrome Scale (PANSS) in un gruppo di pazienti affetti da psicosi all'esordio nell'ambito del progetto SGAP "Sicilian Genetic and Psychosis" svolto in collaborazione con il GAP Study dell'Institute of Psychiatry, King's College of London.

psicosi insight PANSS schizofrenia esordio psicotico SGAP
researchProduct